Novel dimeric DOTA-coupled peptidic Y1-receptor antagonists for targeting of neuropeptide Y receptor-expressing cancers
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2191-219X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Novel dimeric DOTA-coupled peptidic Y1-receptor antagonists for targeting of neuropeptide Y receptor-expressing cancers ; volume:1 ; number:1 ; day:2 ; month:9 ; year:2011 ; pages:1-11 ; date:12.2011
EJNMMI Research ; 1, Heft 1 (2.9.2011), 1-11, 12.2011
- Urheber
-
Chatenet, David
Cescato, Renzo
Waser, Beatrice
Erchegyi, Judit
Rivier, Jean E.
Reubi, Jean Claude
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/2191-219X-1-21
- URN
-
urn:nbn:de:101:1-2021081411593455062572
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chatenet, David
- Cescato, Renzo
- Waser, Beatrice
- Erchegyi, Judit
- Rivier, Jean E.
- Reubi, Jean Claude
- SpringerLink (Online service)
Ähnliche Objekte (12)
Leukotriene Receptor Antagonists
Piperazine‐based P2X4 receptor antagonists
Investigation of the binding site of agonists and antagonists at the human neuropeptide Y receptor family
Why are mineralocorticoid receptor antagonists cardioprotective?
Mineralocorticoid receptor antagonists in dialysis patients
Neurokinin 1 Receptor Antagonists for Pruritus
Structural characterization of neuropeptide Y receptor activation
Azologization of serotonin 5-HT3 receptor antagonists
Irreversible Antagonists for the Adenosine A2B Receptor
Regulation of neuropeptide Y receptor activation and trafficking
Molecular characterization of the human neuropeptide Y5 receptor
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists
Leukotriene Receptor Antagonists
Piperazine‐based P2X4 receptor antagonists
Investigation of the binding site of agonists and antagonists at the human neuropeptide Y receptor family
Why are mineralocorticoid receptor antagonists cardioprotective?
Mineralocorticoid receptor antagonists in dialysis patients
Neurokinin 1 Receptor Antagonists for Pruritus
Structural characterization of neuropeptide Y receptor activation
Azologization of serotonin 5-HT3 receptor antagonists
Irreversible Antagonists for the Adenosine A2B Receptor
Regulation of neuropeptide Y receptor activation and trafficking
Molecular characterization of the human neuropeptide Y5 receptor
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists
Leukotriene Receptor Antagonists
Piperazine‐based P2X4 receptor antagonists
Investigation of the binding site of agonists and antagonists at the human neuropeptide Y receptor family
Why are mineralocorticoid receptor antagonists cardioprotective?
Mineralocorticoid receptor antagonists in dialysis patients
Neurokinin 1 Receptor Antagonists for Pruritus
Structural characterization of neuropeptide Y receptor activation
Azologization of serotonin 5-HT3 receptor antagonists
Irreversible Antagonists for the Adenosine A2B Receptor
Regulation of neuropeptide Y receptor activation and trafficking
Molecular characterization of the human neuropeptide Y5 receptor